Η IBA συμμετέχει ενεργά στην παγκόσμια εκστρατεία για την ενίσχυση της επιστημονικής τεκμηρίωσης της Πρωτονοθεραπείας
Louvain-la-Neuve, Belgium, June 10, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of proton therapy solutions for the treatment of cancer, today announced a sponsored research agreement with The University of Texas MD Anderson Cancer Center aimed at advancing health economics evidence generation for […]